SENSEX
NIFTY
GOLD
USD/INR

Weather

image 25    C

Economy News

The Economic Times

Economy / The Economic Times

details

Ashwagandhas 24-week safety test brings reassuring findings: Report

A clinical trial involving 1,200 adults evaluated the safety of standardised ashwagandha root extract. Participants took either ashwagandha or a placebo for 24 weeks without adverse effects on liver or kidney function. The study monitored participants' immune responses following COVISHIELD vaccination. Results indicated that ashwagandha did not impact virus-neutralising activity compared to the placebo group. This trial adds to the evidence supporting the safety of Ayurveda interventions.

29 Sep 2026 8:35 pm